Parsaclisib Has Activity in Patients With B-Cell Malignancies

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-rw2019-031
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Targeting of B-Cell Receptor Signalling in B-Cell Malignancies

Journal of Internal Medicine
Internal Medicine
2017English

Camrelizumab Has Activity in Patients With Nasopharyngeal Carcinoma

Cancer Discovery
Oncology
2018English

Vemurafenib Has Activity in Patients With BRAFV600-Mutant Glioma

Cancer Discovery
Oncology
2018English

HIV-specific B Cell Response in Patients With Broadly Neutralizing Serum Activity

Science
MultidisciplinaryPhilosophy of ScienceHistory
2015English

Tolerability of Obinutuzumab Therapy in Patients With Rituximab-Relapsed/Refractory B-Cell Malignancies - A Retrospective Single Center Cohort Study

Oncotarget
Oncology
2018English

Mesenchymal Stem Cell Infusion in Haploidentical Hematopoietic Stem Cell Transplantation in Patients With Hematological Malignancies

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Trabectedin Plus Olaparib Has Activity in Patients With Soft-Tissue Sarcoma

Cancer Discovery
Oncology
2018English

Second Malignancies in B-Cell Chronic Lymphocytic Leukaemia: Possible Association With Human Papilloma Virus

British Journal of Haematology
Hematology
2010English

Spectrum of P53 Mutations in Low-Grade B-Cell Malignancies

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy